JP6475162B2 - プレバイオティックチラコイド組成物 - Google Patents

プレバイオティックチラコイド組成物 Download PDF

Info

Publication number
JP6475162B2
JP6475162B2 JP2015530443A JP2015530443A JP6475162B2 JP 6475162 B2 JP6475162 B2 JP 6475162B2 JP 2015530443 A JP2015530443 A JP 2015530443A JP 2015530443 A JP2015530443 A JP 2015530443A JP 6475162 B2 JP6475162 B2 JP 6475162B2
Authority
JP
Japan
Prior art keywords
composition
thylakoid
prebiotic
bacteria
thylakoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015530443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533484A (ja
JP2015533484A5 (enExample
Inventor
ペル−オーケ アルベルトソン
ペル−オーケ アルベルトソン
アルベルトソン カルロッテ エルランソン
アルベルトソン カルロッテ エルランソン
Original Assignee
ティラビスコ アーベー
ティラビスコ アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティラビスコ アーベー, ティラビスコ アーベー filed Critical ティラビスコ アーベー
Publication of JP2015533484A publication Critical patent/JP2015533484A/ja
Publication of JP2015533484A5 publication Critical patent/JP2015533484A5/ja
Application granted granted Critical
Publication of JP6475162B2 publication Critical patent/JP6475162B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
JP2015530443A 2012-09-11 2013-09-10 プレバイオティックチラコイド組成物 Active JP6475162B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1251019 2012-09-11
SE1251019-4 2012-09-11
PCT/EP2013/068656 WO2014040962A1 (en) 2012-09-11 2013-09-10 Prebiotic thylakoid composition

Publications (3)

Publication Number Publication Date
JP2015533484A JP2015533484A (ja) 2015-11-26
JP2015533484A5 JP2015533484A5 (enExample) 2016-10-27
JP6475162B2 true JP6475162B2 (ja) 2019-02-27

Family

ID=49209335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530443A Active JP6475162B2 (ja) 2012-09-11 2013-09-10 プレバイオティックチラコイド組成物

Country Status (13)

Country Link
US (1) US20150209396A1 (enExample)
EP (1) EP2895012B1 (enExample)
JP (1) JP6475162B2 (enExample)
KR (1) KR20150053769A (enExample)
CN (1) CN104780783A (enExample)
AU (1) AU2013314410B2 (enExample)
BR (1) BR112015005355A2 (enExample)
CA (1) CA2884281C (enExample)
DK (1) DK2895012T3 (enExample)
ES (1) ES2656619T3 (enExample)
NO (1) NO2895012T3 (enExample)
WO (1) WO2014040962A1 (enExample)
ZA (1) ZA201502431B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015091739A2 (en) * 2013-12-18 2015-06-25 Thylabisco Ab Use of thylakoids to reduce the urge for palatable food
WO2016177682A1 (en) * 2015-05-06 2016-11-10 Snipr Technologies Limited Altering microbial populations & modifying microbiota
JP6551934B2 (ja) * 2015-12-18 2019-07-31 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
JP7244977B2 (ja) * 2016-03-11 2023-03-23 シオノギヘルスケア株式会社 腸内細菌叢調整用組成物
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043217A1 (en) 1998-02-24 1999-09-02 Md Foods A.M.B.A. Use of d-tagatose as a prebiotic food component
US20030165557A1 (en) * 2000-09-19 2003-09-04 Sunstar, Inc. Food, medicine and method relating to Bifidobacterium proliferation promoting action, allergy preventive action and human cholesterol lowering action
JP2006025669A (ja) * 2004-07-14 2006-02-02 Kumamotoken Kajitsu Nogyo Kyodo Kumiai Rengokai 飲料の製造法
US7700139B2 (en) * 2004-12-30 2010-04-20 Commonwealth Scientific And Industrial Research Organization Method and means for improving bowel health
EP3417868A1 (en) 2005-06-10 2018-12-26 Thylabisco AB Composition
JP4819767B2 (ja) * 2006-12-12 2011-11-24 株式会社エス・エフ・シー イグサ青汁
US20080175899A1 (en) * 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
CN101278752A (zh) * 2008-01-29 2008-10-08 梁季鸿 即食卡尼汀天然果蔬饮料干粉系列配方及生产工艺
EP2320919B1 (en) 2008-07-14 2016-03-30 Thylabisco Ab Large-scale process for the preparation of thylakoids
EP3181134B1 (en) * 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions
EP2678003A1 (en) * 2011-02-25 2014-01-01 Thylabisco AB Composition comprising thylakoids for delaying the uptake of molecules

Also Published As

Publication number Publication date
CA2884281C (en) 2021-01-05
AU2013314410B2 (en) 2017-02-23
CA2884281A1 (en) 2014-03-20
AU2013314410A1 (en) 2015-04-16
BR112015005355A2 (pt) 2017-08-08
WO2014040962A1 (en) 2014-03-20
JP2015533484A (ja) 2015-11-26
ZA201502431B (en) 2017-11-29
DK2895012T3 (en) 2018-01-22
EP2895012B1 (en) 2017-10-18
CN104780783A (zh) 2015-07-15
ES2656619T3 (es) 2018-02-27
NO2895012T3 (enExample) 2018-03-17
US20150209396A1 (en) 2015-07-30
KR20150053769A (ko) 2015-05-18
EP2895012A1 (en) 2015-07-22

Similar Documents

Publication Publication Date Title
US12048721B2 (en) Compositions of microbiota and methods related thereto
Lim et al. Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression
Montelius et al. Feeding spinach thylakoids to rats modulates the gut microbiota, decreases food intake and affects the insulin response
KR101864347B1 (ko) 락토바실러스 람노수스 lm1019 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물
Önal Darilmaz et al. The effects of inulin as a prebiotic supplement and the synbiotic interactions of probiotics to improve oxalate degrading activity
EP3368053A1 (en) Faecalibacterium prausnitzii and desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseases
AU2013314410B2 (en) Prebiotic thylakoid composition
Li et al. Apple polysaccharide could promote the growth of Bifidobacterium longum
Ramos-Romero et al. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats
JP2026008765A (ja) シンバイオティクスの、グルカゴン様ペプチド－１を上昇させる組成物の調製における用途
Tsai et al. Yeast with bacteriocin from ruminal bacteria enhances glucose utilization, reduces ectopic fat accumulation, and alters cecal microbiota in dietary-induced obese mice
Gong et al. Effects of Tibetan Sheep–Derived Compound Probiotics on Growth Performance, Immune Function, Intestinal Tissue Morphology, and Intestinal Microbiota in Mice
WO2025188448A1 (en) Precision probiotics for blood glucose control
CN120944733A (zh) 用于预防和/或治疗代谢性疾病的戊糖片球菌
Hartman et al. A General Overview of the Impact of Yogurt on Health
EP2280612A1 (en) Method for maintaining intestial bacteria in balance

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160908

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160908

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170815

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180612

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180823

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190122

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190131

R150 Certificate of patent or registration of utility model

Ref document number: 6475162

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250